Clinical Stage III Gastric Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0113386 (Clinical Stage III Gastric Cancer AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04535401Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesTreatment